For example, gene therapy to enhance Cav-1 expression in cortical neurons has been proposed to alleviate other forms of neurodegenerative disease (Leske et al., 2007), it is thus possible that similar approaches may have a resultant neuroprotective effect in the eye. This evidence concerns the gene CAV1 and neurodegenerative disease.